Skip to main content
Select Search Option
Menu
Weill Cornell Medicine
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
Richard T. Silver MD Myeloproliferative Neoplasms Center
Richard T. Silver MD Myeloproliferative Neoplasms Center
Explore this Website
  • Home
  • For Patients
    • Conditions
      • Chronic Myeloid Leukemia
      • Essential Thrombocythemia
      • Myelofibrosis
      • Polycythemia Vera
      • Chronic Eosinophilic Leukemias
      • MDS/MPN
      • MPN-Unclassifiable
      • Mastocytosis
    • Complications
      • Bleeding
      • Cardiovascular Disease (heart failure, pulmonary artery hypertension)
      • Depression and other mood disorders
      • Diarrhea and other gastrointestinal complications
      • Pregnancy and MPNs
      • Pruritus (Itching)
      • Thrombosis/Blood Clots
      • Sexual Dysfunction
    • Treatments
      • Anagrelide (Agrylin®)
      • Anti-Coagulants
      • Aspirin
      • Bone Marrow Transplant
      • Bosutinib (Bosulif®)
      • Clopidogrel (Plavix®)
      • DNA Hypomethylating Agents (DHAs)
      • Dasatinib (Sprycel®)
      • Erythropoiesis-Stimulating Agents (ESAs)
      • Hydroxyurea
      • Imatinib (Gleevec®)
      • Interferons
      • Lenalidomide (Revlimid®)
      • Nilotinib (Tasigna®)
      • Phosphorous-32
      • Ponatinib (Iclusig®)
      • Prednisone
      • Ruxolitnib
      • Tyrosine Kinase Inhibitors (TKIs)
    • Frequently Asked Questions
    • Resources
    • Your First Visit
    • Request an Appointment
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations
      • Essential Thrombocythemia (ET)
  • News and Updates
    • Events
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions
  • Weill Cornell Medicine
  • Care
  • Discover
  • Teach
  • Home
  • For Patients
  • For Professionals
  • News and Updates
  • Research and Clinical Trials
  • About Us
  • Home
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions

About Us

The Richard T. Silver Myeloproliferative Neoplasm (MPN) Center is dedicated to providing cutting-edge care to patients with MPNs and advancing the science to find cures. By bringing together a multidisciplinary team of expert physicians and scientists, the Silver MPN Center offers the best possible treatment for MPNs and their side effects.


Silver MPN Center Leadership

Meet the Silver MPN Center leadership team.

Our Team

At the Silver MPN Center, our team of experts is equipped to accurately diagnose, treat and manage all of the myeloproliferative neoplasms and their related complications.

Our Research

At the Silver MPN Center we are committed to moving the medical field forward and curing MPNs through innovative research. Learn more about our laboratory research projects, clinical and translational research initiatives and open clinical trials.

Make a Difference

The Silver MPN Center provides cutting-edge care to patients while advancing the science to develop cures. The support of generous donors and partners who share our mission and patients who participate in clinical trials makes these advances possible.

Thanks to Our Supporters

Cancer Research and Treatment Fund (CR&T)
(646) 962-2727
Request an Appointment Medical Records Make a Difference Email List

Richard T. Silver MD Myeloproliferative Neoplasms Center 520 E 70th Street Starr Pavillion, 341 New York, NY 10021 SilverMPNCenter@med.cornell.edu

Jump To Top
Our Location
Richard T. Silver MD Myeloproliferative Neoplasms Center
Contact Us
  • Twitter
  • Facebook
  • YouTube
520 E 70th Street Starr Pavillion, 341
New York, NY 10021
Phone: (646) 962-2727
Fax: (646) 962-0115
  • For Patients
    • Conditions
      • Chronic Myeloid Leukemia
      • Essential Thrombocythemia
      • Myelofibrosis
      • Polycythemia Vera
      • Chronic Eosinophilic Leukemias
      • MDS/MPN
      • MPN-Unclassifiable
      • Mastocytosis
    • Complications
      • Bleeding
      • Cardiovascular Disease (heart failure, pulmonary artery hypertension)
      • Depression and other mood disorders
      • Diarrhea and other gastrointestinal complications
      • Pregnancy and MPNs
      • Pruritus (Itching)
      • Thrombosis/Blood Clots
      • Sexual Dysfunction
    • Treatments
      • Anagrelide (Agrylin®)
      • Anti-Coagulants
      • Aspirin
      • Bone Marrow Transplant
      • Bosutinib (Bosulif®)
      • Clopidogrel (Plavix®)
      • DNA Hypomethylating Agents (DHAs)
      • Dasatinib (Sprycel®)
      • Erythropoiesis-Stimulating Agents (ESAs)
      • Hydroxyurea
      • Imatinib (Gleevec®)
      • Interferons
      • Lenalidomide (Revlimid®)
      • Nilotinib (Tasigna®)
      • Phosphorous-32
      • Ponatinib (Iclusig®)
      • Prednisone
      • Ruxolitnib
      • Tyrosine Kinase Inhibitors (TKIs)
    • Frequently Asked Questions
    • Resources
    • Your First Visit
    • Request an Appointment
  • For Professionals
    • Refer a Patient
    • Featured Publications
    • Treatment Guidelines and Recommendations
      • Essential Thrombocythemia (ET)
  • News and Updates
    • Events
  • Research and Clinical Trials
    • Open MPN Clinical Trials
    • Our Research
  • About Us
    • Our Approach
    • Our Team
    • Leadership
    • Make a Difference
    • Directions
Care. Discover. Teach. With a legacy of putting patients first, Weill Cornell Medicine is committed to providing exemplary and individualized clinical care, making groundbreaking biomedical discoveries, and educating generations of exceptional doctors and scientists.
Weill Cornell Medicine NewYork - Presbyterian
© Weill Cornell Medicine.
  • Privacy & Legal
  • Careers
  • Giving
  • Directory
  • Web Accessibility Assistance